Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Significance of cycle 1 bone marrow biopsy in predicting outcomes and toxicities of venetoclax-based therapy for myeloid malignancies.
Journal: Leukemia & lymphoma
Published: December 27, 2024
Chemoresistance of TP53 mutant acute myeloid leukemia requires the mevalonate byproduct, geranylgeranyl pyrophosphate, for induction of an adaptive stress response.
Journal: Leukemia
Published: December 05, 2024
Novel Inhibitors for MDM2-MDM4 E3 Ligase Potently Induce p53-Indepedent Apoptosis in Drug-Resistant Leukemic Cells.
Journal: Molecules (Basel, Switzerland)
Published: December 05, 2024
Gemtuzumab ozogamicin plus standard induction hemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia.
Journal: Blood cancer journal
Published: July 08, 2023
Location, location, location: A mini-review of CEBPA variants in patients with acute myeloid leukemia.
Journal: Leukemia research reports
Published: May 01, 2023
Evaluation of hypereosinophilia in a case of FLT3-mutant acute myeloid leukemia treated with gilteritinib.
Journal: Cold Spring Harbor molecular case studies
Published: February 01, 2023
LNS8801 inhibits Acute Myeloid Leukemia by Inducing the Production of Reactive Oxygen Species and Activating the Endoplasmic Reticulum Stress Pathway.
Journal: Cancer research communications
Published: November 23, 2022
Relapsed Acute Myeloid Leukemia Presenting as Multiple Breast Masses: A Case Report.
Journal: Journal of the Korean Society of Radiology
Published: April 30, 2022
Last Updated: 09/26/2026